摘要
目的探讨细胞色素P4501A1(CYP1A1)MspⅠ基因型和异亮氨酸(Ile)-缬氨酸(Val)基因型与肺癌易感性的关系。方法以病例-对照的研究方法,采用PCR-RFLP和ASA技术检测59例原发性肺癌、59名住院对照和73名健康对照CYP1A1MspⅠ和Ile-Val基因型。结果MspⅠ纯合突变型C和缬氨酸纯合型(Val/Val)在病例组各占25.4%和11.9%,对照组中平均各占16.5%和7.0%,相比较无显著性差异(P>0.05)。未发现吸烟与MspⅠC型和Val/Val型有关。在非吸烟组MspⅠC型者患肺癌的危险性(OR)是其他基因型的2.43~2.91倍(95%可信限:1.12~5.25和1.13~7.52),MspⅠ杂合型B在健康对照和病例组分别占61.6%和37.3%(P<0.01),OR为0.37(95%可信限:0.17~0.80)。Ile/Val杂合型在医院对照组占81.4%,病例组为55.9%,差异极显著(P<0.01),OR为0.29(95%可信限:0.12~0.72)。有家族肿瘤史的肺癌Val/Val型占50%(3/6),显著高于对照组(0/18),P<0.01。结论MspⅠC型?
Objective To assess the possible association between the polymorphisms of CYP1A1 and the susceptibility of lung cancer so as to provide clues for genetic markers of lung cancer. Methods CYP1A1 rare genotypes MspⅠ C and VV were detected with the methods of PCR RFLP and ASA in a case control study including 59 cases of lung cancer, 59 hospital controls and 73 healthy controls. ResultsThe frequencies of rare genotypes C and VV of the lung cancer cases were not significantly different from those of the controls, though the frequency of C(25.4%) of the lung cancer cases was higher than that (16.5%) of the controls. However, in the non smoking group with genotype C, the risk of lung cancers was 2.43 2.91 times greater than that of the controls. Heterozygote B was overpresented in healthy controls (61.6%), compared to that of lung cancer cases (37.3%), P<0 01 , odds ratio 0.37(95% confidence interval 0.17 0.80). Conclusion Genotype C may be one of the susceptibly genetic markers of lung cancer in the non smoking population. The risk of lung cancer can be decreased in persons with heterozygote.
出处
《中华医学遗传学杂志》
EI
CAS
CSCD
北大核心
1999年第1期26-28,共3页
Chinese Journal of Medical Genetics
基金
美国中华医学会基金